Cargando…
Clinical Utility of a Novel Coronary Heart Disease Risk‐Assessment Test to Further Classify Intermediate‐Risk Patients
BACKGROUND: Current coronary heart disease (CHD) risk assessments inadequately assess intermediate‐risk patients, leaving many undertreated and vulnerable to heart attacks. A novel CHD risk‐assessment (CHDRA) tool was developed for intermediate‐risk stratification using biomarkers and established ri...
Autores principales: | Solomon, Matthew D., Tirupsur, Ahalya, Hytopoulos, Evangelos, Beggs, Michael, Harrington, Douglas S., French, Cynthia, Quertermous, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231217/ https://www.ncbi.nlm.nih.gov/pubmed/23929798 http://dx.doi.org/10.1002/clc.22185 |
Ejemplares similares
-
Coronary artery calcium testing in low-intermediate risk symptomatic patients with suspected coronary artery disease: An effective gatekeeper to further testing?
por: Mahmood, Tahir, et al.
Publicado: (2020) -
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
por: Kishan, Amar U., et al.
Publicado: (2019) -
Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease
por: Webb, Thomas R., et al.
Publicado: (2017) -
Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020) -
Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk
por: Sevilla-González, Magdalena del Rocío, et al.
Publicado: (2021)